Alta Partners Management VIII, LLC's Net Worth

$0

Who is Alta Partners Management VIII, LLC?

Alta Partners Management VIII, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., and ATS MEDICAL INC.

SEC CIK

Alta Partners Management VIII, LLC's CIK is 0001399894

Past Insider Trading and Trends

2023 was Alta Partners Management VIII, LLC's most active year for acquiring shares with 1 total transactions. Alta Partners Management VIII, LLC's most active month to acquire stocks was the month of July. 2023 was Alta Partners Management VIII, LLC's most active year for disposing of shares, totalling 1 transactions. Alta Partners Management VIII, LLC's most active month to dispose stocks was the month of July. 2023 saw Alta Partners Management VIII, LLC paying a total of $0.00 for 1,463,378 shares, this is the most they've acquired in one year. In 2023 Alta Partners Management VIII, LLC cashed out on 1,463,378 shares for a total of $0.00, their largest year based on trade value.